AZD9291 Resistance Reversal Activity of a pH‐Sensitive Nanocarrier Dual‐Loaded with Chloroquine and FGFR1 Inhibitor in NSCLC
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
AZD9291 Resistance Reversal Activity of a pH‐Sensitive Nanocarrier Dual‐Loaded with Chloroquine and FGFR1 Inhibitor in NSCLC ; volume:8 ; number:2 ; year:2021
Advanced science ; 8, Heft 2 (2021)
- Urheber
-
Gu, Yu
Lai, Songtao
Dong, Yang
Fu, Hao
Song, Liwei
Chen, Tianxiang
Duan, Yourong
Zhang, Zhen
- DOI
-
10.1002/advs.202002922
- URN
-
urn:nbn:de:101:1-2021020407552644906986
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gu, Yu
- Lai, Songtao
- Dong, Yang
- Fu, Hao
- Song, Liwei
- Chen, Tianxiang
- Duan, Yourong
- Zhang, Zhen
Ähnliche Objekte (12)
Zeolitic imidazolate framework‐8 as pH‐sensitive nanocarrier for “Arsenic Trioxide” drug delivery
B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC
FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression
FGFR1-Expression und Genkopienanzahl beim Lungenkarzinom
Activating FGFR1 Mutations in Sporadic Pheochromocytomas
Exosomes: Promising nanocarrier for cancer therapy
FGFR1 wild-type rosette-forming glioneuronal tumours
Untersuchung des unterschiedlichen Therapieansprechens FGFR1-amplifizierter Lungenkrebszellen
Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
Temperature- and pH-sensitive nanogels via photocrosslinking
Zeolitic imidazolate framework‐8 as pH‐sensitive nanocarrier for “Arsenic Trioxide” drug delivery
B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC
FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression
FGFR1-Expression und Genkopienanzahl beim Lungenkarzinom
Activating FGFR1 Mutations in Sporadic Pheochromocytomas
Exosomes: Promising nanocarrier for cancer therapy
FGFR1 wild-type rosette-forming glioneuronal tumours
Untersuchung des unterschiedlichen Therapieansprechens FGFR1-amplifizierter Lungenkrebszellen
Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
Temperature- and pH-sensitive nanogels via photocrosslinking
Zeolitic imidazolate framework‐8 as pH‐sensitive nanocarrier for “Arsenic Trioxide” drug delivery
B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC
FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression
FGFR1-Expression und Genkopienanzahl beim Lungenkarzinom
Activating FGFR1 Mutations in Sporadic Pheochromocytomas
Exosomes: Promising nanocarrier for cancer therapy
FGFR1 wild-type rosette-forming glioneuronal tumours
Untersuchung des unterschiedlichen Therapieansprechens FGFR1-amplifizierter Lungenkrebszellen
Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer